These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7599395)

  • 1. Topical phenytoin accelerates healing in epidermolysis bullosa simplex.
    Masgrau-Peya E; Lacour M; Salomon D
    Dermatology; 1995; 190(3):254. PubMed ID: 7599395
    [No Abstract]   [Full Text] [Related]  

  • 2. [Epidermolysis bullosa herpetiformis of Dowling-Meara].
    Larrègue M; Bressieux JM; Fusade T; Matard B; Crampon P; Salhi A
    Ann Dermatol Venereol; 1990; 117(11):802-4. PubMed ID: 2151589
    [No Abstract]   [Full Text] [Related]  

  • 3. Aluminum chloride hexahydrate and blistering in epidermolysis bullosa simplex.
    Younger IR; Priestley GC; Tidman MJ
    J Am Acad Dermatol; 1990 Nov; 23(5 Pt 1):930-1. PubMed ID: 2254479
    [No Abstract]   [Full Text] [Related]  

  • 4. [Phenytoin therapy in recessive dystrophic epidermolyses (epidermolysis bullosa dystrophica type Hallopeau-Siemens and epidermolysis bullosa dystrophica inversa)].
    Wirth H; Nesch A; Ostapowicz B; Anton-Lamprecht I
    Z Hautkr; 1983 Apr; 58(8):555-74. PubMed ID: 6858283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical Diacerein Ointment for Epidermolysis Bullosa Simplex: A Review.
    Limmer AL; Nwannunu CE; Shah R; Coleman K; Patel RR; Mui UN; Tyring SK
    Skin Therapy Lett; 2019 May; 24(3):7-9. PubMed ID: 31095348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral erythromycin therapy in epidermolysis bullosa simplex generalized severe.
    Chiaverini C; Fontas E; Vabres P; Bessis D; Mazereeuw J; Charlesworth A; Meneguzzi G; Lacour JP
    Br J Dermatol; 2015 Aug; 173(2):563-4. PubMed ID: 25601422
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic efficacy of phenytoin in recessive dystrophic epidermolysis. A comparison of short- and long-term treatment.
    Cooper TW; Bauer EA
    Arch Dermatol; 1984 Apr; 120(4):490-5. PubMed ID: 6703753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive response to 5HT-2 antagonists in a family affected by epidermolysis bullosa Dowling-Meara type.
    Tadini G; Ermacora E; Cambiaghi S; Brusasco A; Cavalli R
    Dermatology; 1993; 186(1):80. PubMed ID: 8435526
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of efficacy of phenytoin in recessive dystrophic epidermolysis bullosa. Epidermolysis Bullosa Study Group.
    Caldwell-Brown D; Stern RS; Lin AN; Carter DM
    N Engl J Med; 1992 Jul; 327(3):163-7. PubMed ID: 1608407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, split-body, single-blinded clinical trial of topical broccoli sprout extract: Assessing the feasibility of its use in keratin-based disorders.
    Kerns ML; Guss L; Fahey J; Cohen B; Hakim JM; Sung S; Lu RG; Coulombe PA
    J Am Acad Dermatol; 2017 Mar; 76(3):449-453.e1. PubMed ID: 27889290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenytoin therapy of recessive dystrophic epidermolysis bullosa. Clinical trial and proposed mechanism of action on collagenase.
    Bauer EA; Cooper TW; Tucker DR; Esterly NB
    N Engl J Med; 1980 Oct; 303(14):776-81. PubMed ID: 6251365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermolysis bullosa simplex complicated by allergic contact dermatitis caused by a hydrocolloid dressing.
    Müller S; Kiritsi D
    Contact Dermatitis; 2017 Mar; 76(3):185-186. PubMed ID: 28220564
    [No Abstract]   [Full Text] [Related]  

  • 13. Tetracycline and epidermolysis bullosa simplex: a double-blind, placebo-controlled, crossover randomized clinical trial.
    Weiner M; Stein A; Cash S; de Leoz J; Fine JD
    Br J Dermatol; 2004 Mar; 150(3):613-4. PubMed ID: 15030362
    [No Abstract]   [Full Text] [Related]  

  • 14. Botulinum toxin in the treatment of sweat-worsened foot problems in patients with epidermolysis bullosa simplex and pachyonychia congenita.
    Swartling C; Karlqvist M; Hymnelius K; Weis J; Vahlquist A
    Br J Dermatol; 2010 Nov; 163(5):1072-6. PubMed ID: 20618323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial.
    Wally V; Hovnanian A; Ly J; Buckova H; Brunner V; Lettner T; Ablinger M; Felder TK; Hofbauer P; Wolkersdorfer M; Lagler FB; Hitzl W; Laimer M; Kitzmüller S; Diem A; Bauer JW
    J Am Acad Dermatol; 2018 May; 78(5):892-901.e7. PubMed ID: 29410318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenytoin and junctional epidermolysis bullosa.
    Armoni M; Schlesinger M; Vardy PA; Metzker A
    Arch Dermatol; 1985 Feb; 121(2):168-9. PubMed ID: 3977324
    [No Abstract]   [Full Text] [Related]  

  • 17. Phenytoin therapy for junctional epidermolysis bullosa.
    Rogers RB; Yancey KB; Allen BS; Guill MF
    Arch Dermatol; 1983 Nov; 119(11):925-6. PubMed ID: 6639114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of topical phenytoin for healing of chronic venous ulcerations.
    Hokkam E; El-Labban G; Shams M; Rifaat S; El-Mezaien M
    Int J Surg; 2011; 9(4):335-8. PubMed ID: 21338720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effectiveness of phenytoin in the treatment of epidermolysis bullosa hereditaria dystrophica partim inversa (Gedde-Dahl)].
    Bandmann HJ; Perwein E
    Z Hautkr; 1982 Nov; 57(21):1587-98. PubMed ID: 7148073
    [No Abstract]   [Full Text] [Related]  

  • 20. The prevalence of epidermolysis bullosa in Scotland.
    Horn HM; Priestley GC; Eady RA; Tidman MJ
    Br J Dermatol; 1997 Apr; 136(4):560-4. PubMed ID: 9155958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.